1/14
Looks like no tags are added yet.
What happens to plasma concentration (Cp) and elimination rate during a constant-rate intravenous infusion?
As the drug is infused at a constant rate, Cp rises and the rate of elimination increases proportionally (1st-order kinetics) until rate of infusion equals rate of elimination, reaching a plateau called steady-state concentration (Css).
Give the equation for the rate of infusion required to reach a target steady-state concentration (Css).
Rate of infusion = Css × Cl (where Cl is clearance).
How many half-lives does it take to effectively reach steady-state concentration (Css), and does the infusion rate change this time?
It takes approximately 5 half-lives (50% after 1 t0.5, 75% after 2, 87.5% after 3, >95% after 5). The time to reach Css depends ONLY on t0.5 and does NOT vary with the infusion rate.
How does changing the infusion rate affect Css, and how long does it take to reach the new Css or wash out after stopping?
Doubling the infusion rate doubles Css (since Cl is constant). Reaching a new Css after changing the rate—or clearing ~97% of the drug after stopping the infusion—also takes about 5 half-lives.
How do you rapidly reach Css during an IV infusion for a drug with a very long half-life?
Administer a high initial loading infusion to reach the target Css quickly, then switch to a lower maintenance infusion to sustain it.
Give the equation for average steady-state plasma concentration (Css,av) during repeated oral dosing and define each variable.
Css,av = (D × F) / (T × Cl), where D = individual dose, F = oral bioavailability (0 to 1), T = time interval between doses, and Cl = clearance.
If you double the oral dose (D) and double the dosing interval (T), what happens to Css,av and plasma fluctuations?
Css,av stays the same, but peak-to-trough fluctuations around Css,av become much larger (risking toxicity at peaks and loss of efficacy at troughs).
What is the clinical trade-off when choosing the dosing interval (T) for oral medication?
Longer intervals (e.g., once daily) improve patient compliance, while shorter intervals reduce large peak-to-trough fluctuations in plasma concentration.
Name two drugs excreted largely unchanged by the kidney and explain when this property is clinically useful.
Gentamicin and methotrexate. They are useful in patients with liver disease because their half-life is not prolonged by impaired hepatic metabolism.
List the three nephron processes that determine renal drug excretion and where each occurs.
Why are drug metabolites excreted in urine much more efficiently than parent drugs?
Liver metabolism converts lipid-soluble drugs into water-soluble (non-lipid-soluble) metabolites that are actively secreted in the proximal tubule and cannot be passively reabsorbed in the distal tubule.
How does urinary pH affect the reabsorption and excretion of weak acids and weak bases?
Ionised drugs cannot cross membranes and are trapped in urine for excretion. Making urine alkaline increases excretion of weak acids; making urine acidic increases excretion of weak bases.
How do you increase the renal excretion of a weak acid (e.g., aspirin), and what is this called when combined with a diuretic?
Alkalinise the urine using sodium bicarbonate (increases the ionised [A-]/[HA] ratio, preventing passive reabsorption). Combined with a diuretic to increase urine flow, this is called forced alkaline diuresis.
Using the Henderson-Hasselbalch equation for aspirin (pKa = 3.5), how does raising urinary pH from 5 to 7 affect its ionisation ratio?
At pH 5, [A-]/[HA] = 31.6 (antilog 1.5). At pH 7, [A-]/[HA] = 3,162 (antilog 3.5)—a 100-fold increase in the ionised form, drastically boosting excretion.
How do you increase the renal excretion of a weak base (e.g., methamphetamine)?
Acidify the urine (e.g., with ammonium chloride), which shifts the equilibrium toward the protonated, ionised form (RNH3+ + H+ → RNH4+) and prevents passive reabsorption in the distal tubule.